Synthesis and evaluation of the cytotoxic activity of novel ethyl4-[4-(4-substitutedpiperidin-1-yl)] benzyl-phenylpyrrolo[1,2-alpha] quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines